Knowledge of Pap screening and human papillomavirus among women attending clinics in Medellin, Colombia

被引:22
作者
Hanisch, R. [2 ]
Gustat, J. [2 ]
Hagensee, M. E. [3 ]
Baena, A. [1 ]
Salazar, J. E. [1 ]
Castro, M. V. [1 ]
Gaviria, M. [1 ,4 ]
Sanchez, G. I. [1 ]
机构
[1] Univ Antioquia, Sch Med, Grp Infect & Canc, Medellin, Colombia
[2] Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA USA
[3] Louisiana State Univ, Infect Dis Sect, Dept Med, Hlth Sci Ctr, New Orleans, LA USA
[4] Colegio Mayor Antioquia, Escuela Bacteriol, Medellin, Colombia
关键词
cervical cancer screening; Colombia; human papillomavirus; knowledge; Pap screening; survey;
D O I
10.1111/j.1525-1438.2007.01131.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This study evaluated Pap screening and human papillomavirus (HPV) knowledge in a population of Colombian women as a possible contributing factor of low cervical cancer screening success. This is a descriptive, cross-sectional analysis of 454 women who were approached in five different hospitals and clinics throughout Medellin, Colombia. Of them, 449 females agreed to participate and answered a standardized face-to-face questionnaire regarding Pap screening and HPV knowledge. Using logistic regression, predictors of both Pap and HPV knowledge were examined. Overall, 76.3% of the participants exhibited a high level of Pap screening knowledge, while only 7.8% showed high level of HPV knowledge. Of the 449 women, 71.5% reported that it had been 1 year or less since their last Pap test, while 7.8% reported never having had a Pap test or not having had a recent test. Factors influencing Pap screening knowledge included education level and insurance; factors influencing HPV knowledge included education level and age. The high level of Pap screening knowledge and use do not explain the high cervical cancer rates in Colombia. The results of this study suggest that educational efforts should be focused on increasing women's knowledge and awareness of HPV in anticipation of the availability of HPV vaccines and HPV tests for screening.
引用
收藏
页码:1020 / 1026
页数:7
相关论文
共 27 条
[1]   Clinical applications of HPV testing: A summary of meta-analyses [J].
Arbyn, Marc ;
Sasieni, Peter ;
Meijer, Chris J. L. M. ;
Clavel, Christine ;
Koliopoulos, George ;
Dillner, Joakim .
VACCINE, 2006, 24 :78-89
[2]   Trends in cancer mortality in the Americas, 1970-2000 [J].
Bosetti, C ;
Malvezzi, M ;
Chatenoud, L ;
Negri, E ;
Levi, F ;
La Vecchia, C .
ANNALS OF ONCOLOGY, 2005, 16 (03) :489-511
[3]   Determinants of cervical cancer screening in a poor area: results of a population-based survey in Rivas, Nicaragua [J].
Claeys, P ;
Gonzalez, C ;
Gonzalez, M ;
Page, H ;
Bello, RE ;
Temmerman, M .
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2002, 7 (11) :935-941
[4]   Worldwide distribution of human papillomavirus types in cytologically normal women in the international Agency for Research on Cancer HPV prevalence surveys:: a pooled analysis [J].
Clifford, GM ;
Gallus, S ;
Herrero, R ;
Muñoz, N ;
Snijders, PJF ;
Vaccarella, S ;
Anh, PTH ;
Ferreccio, C ;
Hieu, NT ;
Matos, E ;
Molano, M ;
Rajkumar, R ;
Ronco, G ;
de Sanjosé, S ;
Shin, HR ;
Sukvirach, S ;
Thomas, JO ;
Tunsakul, S ;
Meijer, CJLM ;
Franceschi, S .
LANCET, 2005, 366 (9490) :991-998
[5]   New dimensions in cervical cancer screening [J].
Cuzick, Jack ;
Mayrand, Marie Helene ;
Ronco, Guglielmo ;
Snijders, Peter ;
Wardle, Jane .
VACCINE, 2006, 24 :90-97
[6]   Knowledge about human papillomavirus among adolescents [J].
Dell, DL ;
Chen, H ;
Ahmad, F ;
Stewart, DE .
OBSTETRICS AND GYNECOLOGY, 2000, 96 (05) :653-656
[7]  
*DEP ADM PLAN, 2005, AN EST ANT
[8]  
Ferlay J, 2004, GLOBOCAN 2002 CANC I
[9]  
Flores Y, 2003, SALUD PUBLICA MEXICO, V45, pS388
[10]  
Gaviria A, 2003, REV FAC NAC SALUD PU, V21, P43